z-logo
open-access-imgOpen Access
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of duchenne muscular dystrophy
Author(s) -
Tero Puolakkainen,
Hongqiang Ma,
Arja Pasternack,
Heikki Kainulainen,
Olli Ritvos,
Kristiina Heikinheimo,
Juha J. Hulmi,
Riku Kiviranta
Publication year - 2013
Publication title -
bone abstracts
Language(s) - English
Resource type - Journals
ISSN - 2052-1219
DOI - 10.1530/boneabs.01.oc2.1
Subject(s) - duchenne muscular dystrophy , activin receptor , muscular dystrophy , key (lock) , bone mass , mdx mouse , medicine , endocrinology , anatomy , biology , transforming growth factor , dystrophin , osteoporosis , ecology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom